Literature DB >> 7577232

The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.

M W Mosesson1, K R Siebenlist, J F Hainfeld, J S Wall.   

Abstract

When factor XIIIa-mediated crosslinking of fibrin or fibrinogen occurs, reciprocal intermolecular isopeptide bonds form first between paired carboxy terminal gamma chain donor-acceptor sites in outer molecular D domains, resulting in gamma chain dimers. Their location in the fibrin polymer is not certain, but some evidence suggests they are situated at the outermost ends of the D domains of linearly aligned molecules comprising each strand of double-stranded fibrils ("DD-long"). Other experiments indicate that gamma chain bonds are located between D domains in opposing fibril strands ("transverse"). To distinguish between these possible arrangements, we evaluated the ultrastructure of fibrils and fibers found in factor XIIIa-fibrinogen crosslinking mixtures, based on this reasoning: if DD-long bonding occurs, single-stranded fibrils should result, whereas transverse positioning will result in double-stranded fibrils. Fibrils formed in partially cross-linked fibrinogen solutions consisted of two parallel strands, as discerned visually from scanning transmission electron microscopic images and confirmed by mass per unit length fibril measurements. Neighboring fibrinogen D domains in each fibril strand were aligned end-to-end and were in register with a fibrinogen E domain in the opposite strand, creating a half-staggered molecular arrangement with approximately 22.5-nm periodicity corresponding to half the length of fibrinogen. Ribbon-like fibrinogen fibers, like fibrils, displayed 22.5-nm periodicity, as expected from laterally associated double-stranded fibrils with D domains in register. Taken together, these results indicate that carboxy terminal gamma chain bonds are positioned transversely between strands and are represented by thin filamentous structures bridging the D domains of opposing fibril strands--it follows that the same gamma chain crosslink arrangement occurs in fibrin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577232     DOI: 10.1006/jsbi.1995.1033

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  18 in total

Review 1.  Biological liquid crystal elastomers.

Authors:  David P Knight; Fritz Vollrath
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-02-28       Impact factor: 6.237

2.  Longitudinal orientation of cross-linked polypeptide γ chains in fibrin fibrils.

Authors:  M A Rosenfeld; V B Leonova; A V Bychkova; E A Kostanova; M I Biryukova
Journal:  Dokl Biochem Biophys       Date:  2015-10-31       Impact factor: 0.788

3.  Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.

Authors:  Kevin R Siebenlist; Michael W Mosesson; Irene Hernandez; Leslie A Bush; Enrico Di Cera; John R Shainoff; James P Di Orio; Laurie Stojanovic
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

4.  Nanoscale probing reveals that reduced stiffness of clots from fibrinogen lacking 42 N-terminal Bbeta-chain residues is due to the formation of abnormal oligomers.

Authors:  Radwa H Abou-Saleh; Simon D Connell; Robert Harrand; Ramzi A Ajjan; Michael W Mosesson; D Alastair M Smith; Peter J Grant; Robert A S Ariëns
Journal:  Biophys J       Date:  2009-03-18       Impact factor: 4.033

5.  The relationship between the fibrinogen D domain self-association/cross-linking site (gammaXL) and the fibrinogen Dusart abnormality (Aalpha R554C-albumin): clues to thrombophilia in the "Dusart syndrome".

Authors:  M W Mosesson; K R Siebenlist; J f Hainfeld; J S Wall; J Soria; C Soria; J P Caen
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

6.  The complementary aggregation sites of fibrin investigated through examination of polymers of fibrinogen with fragment E.

Authors:  Y Veklich; E K Ang; L Lorand; J W Weisel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

7.  Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology.

Authors:  E A Ryan; L F Mockros; A M Stern; L Lorand
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

8.  The location of the carboxy-terminal region of gamma chains in fibrinogen and fibrin D domains.

Authors:  M W Mosesson; K R Siebenlist; D A Meh; J S Wall; J F Hainfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Fibrinogen nanofibril growth and self-assembly on Au (1,1,1) surface in the absence of thrombin.

Authors:  Guojun Chen; Nanting Ni; Binghe Wang; Bingqian Xu
Journal:  Chemphyschem       Date:  2010-02-22       Impact factor: 3.102

10.  Regulation of endothelial cell barrier function by antibody-driven affinity modulation of platelet endothelial cell adhesion molecule-1 (PECAM-1).

Authors:  Heng Mei; Jay M Campbell; Cathy M Paddock; Panida Lertkiatmongkol; Michael W Mosesson; Ralph Albrecht; Peter J Newman
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.